<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:activity="http://activitystrea.ms/spec/1.0/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Newsvine - jj</title><link>http://www.newsvine.com/jj</link><description>Newsvine - jj</description><language>en-us</language><copyright>Copyright 2013</copyright><lastBuildDate>Fri, 29 Mar 2013 19:39:48 +0000</lastBuildDate><pubDate>Wed, 19 Jun 2013 10:18:09 +0000</pubDate><generator>http://www.newsvine.com</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>FDA OKs first-of-its-kind diabetes drug from J&amp;J</title>
<description><![CDATA[The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar &#8212; flushing it out in patients' urine.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2013/03/29/17519528-fda-oks-first-of-its-kind-diabetes-drug-from-jj</link><guid>http://www.newsvine.com/_news/2013/03/29/17519528-fda-oks-first-of-its-kind-diabetes-drug-from-jj</guid><category>us</category><category>drug</category><category>health</category><category>drug-administration</category><category>jj</category><category>diabetes-drug</category><pubDate>Fri, 29 Mar 2013 19:00:25 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>Disney says JJ Abrams to direct next 'Star Wars'</title>
<description><![CDATA[It's official. The force is with J.J. Abrams.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2013/01/24/16684000-disney-says-jj-abrams-to-direct-next-star-wars</link><guid>http://www.newsvine.com/_news/2013/01/24/16684000-disney-says-jj-abrams-to-direct-next-star-wars</guid><category>entertainment</category><category>us</category><category>star-wars</category><category>us-news</category><category>jj</category><category>abrams</category><pubDate>Thu, 24 Jan 2013 23:25:02 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://m.static.newsvine.com/servista/imagesizer?file=a6acf994-0ac4-40fb-824f-411fef1096c2.jpg&amp;width=400" type="image/jpeg" medium="image" height="273" width="400" ><media:thumbnail url="http://m.static.newsvine.com/servista/imagesizer?file=a6acf994-0ac4-40fb-824f-411fef1096c2.jpg&amp;width=120" width="120" height="82" /><media:description type="plain">&lt;p&gt;FILE - In this Jan. 8, 2013 file photo, J.J. Abrams arrives at the Winter TCA Fox All-Star Party at the Langham Huntington Hotel in Pasadena, Calif. According to multiple reports, Abrams is set to direct the next installment of Star Wars, which Disney has said will be Episode 7 and due out in 2015. Disney bought Star Wars maker Lucasfilm last month for $4.06 billion.  (Photo by Matt Sayles/Invision/AP, File)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>FDA panel backs novel diabetes pill from J&amp;J</title>
<description><![CDATA[A panel of federal health experts ruled Thursday that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked over the long term.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2013/01/10/16451907-fda-panel-backs-novel-diabetes-pill-from-jj</link><guid>http://www.newsvine.com/_news/2013/01/10/16451907-fda-panel-backs-novel-diabetes-pill-from-jj</guid><category>business</category><category>us</category><category>drug</category><category>jj</category><category>diabetes-drug</category><pubDate>Thu, 10 Jan 2013 21:58:57 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>FDA expands approval of J&amp;J prostate cancer drug</title>
<description><![CDATA[The Food and Drug Administration on Monday expanded approval of Johnson & Johnson's prostate cancer pill Zytiga for men with an earlier stage of the disease.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/12/10/15823250-fda-expands-approval-of-jj-prostate-cancer-drug</link><guid>http://www.newsvine.com/_news/2012/12/10/15823250-fda-expands-approval-of-jj-prostate-cancer-drug</guid><category>us</category><category>drug</category><category>health</category><category>cancer-drug</category><category>drug-administration</category><category>prostate-cancer</category><category>jj</category><pubDate>Mon, 10 Dec 2012 19:46:26 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>News Summary: J&amp;J removing harsh chemicals by 2015</title>
<description><![CDATA[NO MORE TEARS: Johnson & Johnson says it will eliminate traces of harsh, potentially dangerous chemicals from nearly all adult cosmetic products by the end of 2015. It's on track to do that with its shampoo and other baby products by the end of 2013.]]></description>
<dc:creator><![CDATA[The Associated Press]]></dc:creator><source><![CDATA[The Associated Press]]></source><link>http://www.newsvine.com/_news/2012/08/15/13297546-news-summary-jj-removing-harsh-chemicals-by-2015</link><guid>http://www.newsvine.com/_news/2012/08/15/13297546-news-summary-jj-removing-harsh-chemicals-by-2015</guid><category>business</category><category>us</category><category>protest</category><category>chemical</category><category>jj</category><category>no-more-tears</category><pubDate>Wed, 15 Aug 2012 15:38:21 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=400" type="image/jpeg" medium="image" height="512" width="341" ><media:thumbnail url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=120" width="120" height="180" /><media:description type="plain">&lt;p&gt;FILE - An April 19, 2010 file photo shows a bottle of Johnson &amp; Johnson's baby shampoo in Philadelphia. Johnson &amp; Johnson said Tuesday Aug. 14, 2012 that it remains on track to have baby products, including its Johnson's No More Tears baby shampoo, reformulated with safer ingredients by the end of 2013.  (AP Photo/Matt Rourke, File)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>J&amp;J removing harsh chemicals from products by 2015</title>
<description><![CDATA[Johnson & Johnson plans to remove trace amounts of potentially cancer-causing and other dangerous chemicals from nearly all its adult toiletries and cosmetic products worldwide within 3 1/2 years.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2012/08/15/13297426-jj-removing-harsh-chemicals-from-products-by-2015</link><guid>http://www.newsvine.com/_news/2012/08/15/13297426-jj-removing-harsh-chemicals-from-products-by-2015</guid><category>ap</category><category>health</category><category>protest</category><category>chemical</category><category>jj</category><pubDate>Wed, 15 Aug 2012 15:29:55 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=400" type="image/jpeg" medium="image" height="512" width="341" ><media:thumbnail url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=120" width="120" height="180" /><media:description type="plain">&lt;p&gt;FILE - An April 19, 2010 file photo shows a bottle of Johnson &amp; Johnson's baby shampoo in Philadelphia. Johnson &amp; Johnson said Tuesday Aug. 14, 2012 that it remains on track to have baby products, including its Johnson's No More Tears baby shampoo, reformulated with safer ingredients by the end of 2013.  (AP Photo/Matt Rourke, File)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>J&amp;J removing harsh chemicals from products by 2015</title>
<description><![CDATA[Johnson & Johnson plans to remove potentially cancer-causing and other dangerous chemicals from nearly all its adult toiletries and cosmetic products worldwide within 3 1/2 years.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2012/08/15/13293209-jj-removing-harsh-chemicals-from-products-by-2015</link><guid>http://www.newsvine.com/_news/2012/08/15/13293209-jj-removing-harsh-chemicals-from-products-by-2015</guid><category>health</category><category>protest</category><category>chemical</category><category>jj</category><pubDate>Wed, 15 Aug 2012 10:01:45 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=400" type="image/jpeg" medium="image" height="512" width="341" ><media:thumbnail url="http://m.static.newsvine.com/servista/imagesizer?file=ce072312-f104-425a-961c-832a1839b495.jpg&amp;width=120" width="120" height="180" /><media:description type="plain">&lt;p&gt;FILE - An April 19, 2010 file photo shows a bottle of Johnson &amp; Johnson's baby shampoo in Philadelphia. Johnson &amp; Johnson said Tuesday Aug. 14, 2012 that it remains on track to have baby products, including its Johnson's No More Tears baby shampoo, reformulated with safer ingredients by the end of 2013.  (AP Photo/Matt Rourke, File)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>J&amp;J, Pfizer to drop intravenous Alzheimer's drug</title>
<description><![CDATA[Pfizer Inc. and Johnson & Johnson said Monday they are ending development of an intravenous formulation of a drug to treat Alzheimer's disease after the treatment failed in two late-stage clinical trials.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/08/06/13148928-jj-pfizer-to-drop-intravenous-alzheimers-drug</link><guid>http://www.newsvine.com/_news/2012/08/06/13148928-jj-pfizer-to-drop-intravenous-alzheimers-drug</guid><category>business</category><category>us</category><category>disease</category><category>pfizer</category><category>jj</category><category>alzheimer-disease</category><pubDate>Mon, 6 Aug 2012 21:34:49 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>Alzheimer's drug fails in 1 study, 2nd continues</title>
<description><![CDATA[A closely watched experimental Alzheimer's treatment has failed to slow the disease in one late-stage study, a big disappointment for doctors and patients but not the end of the road for the drug. Pfizer Inc. said Monday that it will continue to study its effect on a different group of patients.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2012/07/23/12910008-alzheimers-drug-fails-in-1-study-2nd-continues</link><guid>http://www.newsvine.com/_news/2012/07/23/12910008-alzheimers-drug-fails-in-1-study-2nd-continues</guid><category>us</category><category>drug</category><category>health</category><category>pfizer</category><category>us-news</category><category>jj</category><category>alzheimer-drug</category><pubDate>Mon, 23 Jul 2012 21:27:44 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>FDA denies expanded approval of J&amp;J blood thinner</title>
<description><![CDATA[Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto for a new use to prevent life-threatening blood clots in high-risk patients.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/06/21/12345107-fda-denies-expanded-approval-of-jj-blood-thinner</link><guid>http://www.newsvine.com/_news/2012/06/21/12345107-fda-denies-expanded-approval-of-jj-blood-thinner</guid><category>us</category><category>politics</category><category>jj</category><category>blood-thinner</category><pubDate>Thu, 21 Jun 2012 22:45:59 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>FDA denies expanded approval of J&amp;J blood thinner</title>
<description><![CDATA[Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto (ZAR-el-toh) for a new use to prevent life-threatening blood clots in high-risk patients.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/06/21/12344918-fda-denies-expanded-approval-of-jj-blood-thinner</link><guid>http://www.newsvine.com/_news/2012/06/21/12344918-fda-denies-expanded-approval-of-jj-blood-thinner</guid><category>us</category><category>politics</category><category>jj</category><category>bloodthinner</category><pubDate>Thu, 21 Jun 2012 22:28:21 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J to stop selling pelvic mesh tied to lawsuits</title>
<description><![CDATA[Johnson & Johnson plans to stop selling surgical mesh implants used to treat women's health problems, which have been linked to injuries and triggered hundreds of lawsuits.]]></description>
<dc:creator><![CDATA[Matthew Perrone]]></dc:creator><source><![CDATA[Matthew Perrone]]></source><link>http://www.newsvine.com/_news/2012/06/05/12069048-jj-to-stop-selling-pelvic-mesh-tied-to-lawsuits</link><guid>http://www.newsvine.com/_news/2012/06/05/12069048-jj-to-stop-selling-pelvic-mesh-tied-to-lawsuits</guid><category>us</category><category>politics</category><category>implant</category><category>jj</category><category>pelvic</category><pubDate>Tue, 5 Jun 2012 15:58:10 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>FDA panel votes against new use for J&amp;J's Xarelto</title>
<description><![CDATA[A majority of Food and Drug Administration panelists voted against a new use for Johnson & Johnson's blood thinner Xarelto to reduce life-threatening blood clots.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/05/21/11792143-fda-panel-votes-against-new-use-for-jjs-xarelto</link><guid>http://www.newsvine.com/_news/2012/05/21/11792143-fda-panel-votes-against-new-use-for-jjs-xarelto</guid><category>business</category><category>us</category><category>fda</category><category>health</category><category>politics</category><category>drug-administration</category><category>jj</category><category>bloodthinner</category><pubDate>Mon, 21 May 2012 13:59:37 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>EU clears J&amp;J's $21.3BN acquisition of Synthes</title>
<description><![CDATA[The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/04/19/11281139-eu-clears-jjs-213bn-acquisition-of-synthes</link><guid>http://www.newsvine.com/_news/2012/04/19/11281139-eu-clears-jjs-213bn-acquisition-of-synthes</guid><category>business</category><category>eu</category><category>european-union</category><category>jj</category><category>synthes</category><pubDate>Thu, 19 Apr 2012 09:01:17 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J CEO gets 8 pct. pay boost in 2011, to $23M</title>
<description><![CDATA[Johnson & Johnson raised compensation 8 percent last year for outgoing CEO William Weldon, despite a seemingly endless string of product recalls, mediocre 2011 results and ongoing lawsuits and government probes over some products and marketing practices.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2012/03/14/10687717-jj-ceo-gets-8-pct-pay-boost-in-2011-to-23m</link><guid>http://www.newsvine.com/_news/2012/03/14/10687717-jj-ceo-gets-8-pct-pay-boost-in-2011-to-23m</guid><category>business</category><category>us</category><category>executive</category><category>jj</category><category>compensation</category><category>executive-compensation</category><pubDate>Wed, 14 Mar 2012 18:35:45 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/33d42b9d-0cf9-4fa8-a91f-bd2035e22823.jpg" type="image/jpeg" medium="image" height="512" width="340" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/33d42b9d-0cf9-4fa8-a91f-bd2035e22823.jpg" width="120" height="181" /><media:description type="plain">&lt;p&gt;FILE - In a Thursday, Sept. 30, 2010 file photo, Johnson &amp; Johnson Chairman and CEO William Weldon testifies on Capitol Hill in Washington, before the House Oversight and Government Reform Committee hearing. Johnson &amp; Johnson raised compensation 8 percent last year for outgoing CEO Weldon, despite a seemingly endless string of product recalls, mediocre 2011 results and ongoing lawsuits and government probes over some products and marketing  practices. Weldon, who will step down on April 26 but remain chairman of the board for the time being, raked in total compensation valued at $23.4 million last year, up from $21.6 million in 2010. (AP Photo/Kevin Wolf, File)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>J&amp;J offers concessions to EU in Synthes takeover</title>
<description><![CDATA[The European Commission said Wednesday Johnson & Johnson has offered concessions hoping they will convince the EU's antitrust regulator to clear J&J's takeover of Swiss orthopedics maker Synthes.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2012/02/22/10479887-jj-offers-concessions-to-eu-in-synthes-takeover</link><guid>http://www.newsvine.com/_news/2012/02/22/10479887-jj-offers-concessions-to-eu-in-synthes-takeover</guid><category>business</category><category>eu</category><category>european-commission</category><category>jj</category><category>synthes</category><pubDate>Wed, 22 Feb 2012 21:31:02 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J recalls Motrin caplets that may work slowly</title>
<description><![CDATA[Healthcare giant Johnson & Johnson has issued another recall of Motrin pain relievers, at least the sixth in two years.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2011/12/22/9633989-jj-recalls-motrin-caplets-that-may-work-slowly</link><guid>http://www.newsvine.com/_news/2011/12/22/9633989-jj-recalls-motrin-caplets-that-may-work-slowly</guid><category>business</category><category>us</category><category>recall</category><category>jj</category><category>motrin</category><pubDate>Thu, 22 Dec 2011 15:54:37 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>Synthes investors back J&amp;J buyout</title>
<description><![CDATA[Swiss orthopedics maker Synthes says its investors overwhelmingly voted to accept a $21.3 billion acquisition offer from U.S. health care conglomerate Johnson & Johnson.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2011/12/15/9469164-synthes-investors-back-jj-buyout</link><guid>http://www.newsvine.com/_news/2011/12/15/9469164-synthes-investors-back-jj-buyout</guid><category>business</category><category>us</category><category>vote</category><category>jj</category><category>synthes</category><pubDate>Thu, 15 Dec 2011 15:28:41 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J legal chief will to retire in March</title>
<description><![CDATA[Johnson & Johnson says its vice president and general counsel Russ Deyo will retire next year after 27 years with the company.]]></description>
<dc:creator><![CDATA[Associated Press]]></dc:creator><source><![CDATA[Associated Press]]></source><link>http://www.newsvine.com/_news/2011/11/22/8959539-jj-legal-chief-will-to-retire-in-march</link><guid>http://www.newsvine.com/_news/2011/11/22/8959539-jj-legal-chief-will-to-retire-in-march</guid><category>business</category><category>us</category><category>executive</category><category>retiring</category><category>jj</category><category>russ-deyo</category><pubDate>Tue, 22 Nov 2011 21:44:26 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J steadily removing toxins from baby products</title>
<description><![CDATA[Amid pressure from activists, Johnson & Johnson said Wednesday that it is continuing efforts to remove traces of two harmful chemicals from its baby products around the world.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2011/11/16/8842996-jj-steadily-removing-toxins-from-baby-products</link><guid>http://www.newsvine.com/_news/2011/11/16/8842996-jj-steadily-removing-toxins-from-baby-products</guid><category>business</category><category>us</category><category>protest</category><category>chemical</category><category>jj</category><category>us-jj</category><pubDate>Wed, 16 Nov 2011 21:21:21 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>Groups push J&amp;J on baby shampoo chemicals</title>
<description><![CDATA[Two chemicals considered harmful to babies remain in Johnson & Johnson's baby shampoo sold in the U.S., even though the company already makes versions without them, according to a coalition of health and environmental groups.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2011/11/01/8572041-groups-push-jj-on-baby-shampoo-chemicals</link><guid>http://www.newsvine.com/_news/2011/11/01/8572041-groups-push-jj-on-baby-shampoo-chemicals</guid><category>business</category><category>us</category><category>protest</category><category>chemical</category><category>us-news</category><category>jj</category><pubDate>Tue, 1 Nov 2011 04:02:24 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>FDA staff recommends against J&amp;J clotting drug</title>
<description><![CDATA[A negative review from Food and Drug Administration staff bodes ill for a new blood thinner from Johnson & Johnson.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2011/09/06/7633875-fda-staff-recommends-against-jj-clotting-drug</link><guid>http://www.newsvine.com/_news/2011/09/06/7633875-fda-staff-recommends-against-jj-clotting-drug</guid><category>business</category><category>us</category><category>drug</category><category>drug-administration</category><category>jj</category><category>clotting</category><pubDate>Tue, 6 Sep 2011 17:26:18 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>J&amp;J wins US approval for new blood thinner</title>
<description><![CDATA[Johnson & Johnson said Friday that U.S. regulators have approved its new type of blood thinner shown to reduce deadly blood clots in patients who have undergone knee and hip replacements.]]></description>
<dc:creator><![CDATA[Matthew Perrone]]></dc:creator><source><![CDATA[Matthew Perrone]]></source><link>http://www.newsvine.com/_news/2011/07/01/6993503-jj-wins-us-approval-for-new-blood-thinner</link><guid>http://www.newsvine.com/_news/2011/07/01/6993503-jj-wins-us-approval-for-new-blood-thinner</guid><category>business</category><category>us</category><category>new</category><category>health</category><category>jj</category><category>blood-thinner</category><pubDate>Fri, 1 Jul 2011 19:10:40 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item><item><title>Puerto Rico celebrates arrival of Mavericks' Barea</title>
<description><![CDATA[Dallas Mavericks point guard Jose Juan Barea arrived in his native Puerto Rico on Wednesday to a hero's welcome that included a two-hour caravan under a blistering sun.]]></description>
<dc:creator><![CDATA[Raul Colon]]></dc:creator><source><![CDATA[Raul Colon]]></source><link>http://www.newsvine.com/_news/2011/06/22/6920082-puerto-rico-celebrates-arrival-of-mavericks-barea</link><guid>http://www.newsvine.com/_news/2011/06/22/6920082-puerto-rico-celebrates-arrival-of-mavericks-barea</guid><category>nba</category><category>sports</category><category>puerto-rico</category><category>dallas-mavericks</category><category>jj</category><category>barea</category><category>jose-juan-barea</category><pubDate>Wed, 22 Jun 2011 22:00:40 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/fe35985c-dfb7-4f67-a493-af5d84108948.jpg" type="image/jpeg" medium="image" height="267" width="400" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/fe35985c-dfb7-4f67-a493-af5d84108948.jpg" width="120" height="80" /><media:description type="plain">&lt;p&gt;NBA Dallas Mavericks basketball player Jose Juan Barea, top, of Puerto Rico, waves to fans during a welcoming parade in San Juan, Puerto Rico, Wednesday, June 22, 2011. Dallas Mavericks won the last National Basketball Association championship. (AP Photo/Ricardo Arduengo)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/b9b4fc5f-3893-4251-9488-61209a35e8d2.jpg" type="image/jpeg" medium="image" height="267" width="400" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/b9b4fc5f-3893-4251-9488-61209a35e8d2.jpg" width="120" height="80" /><media:description type="plain">&lt;p&gt;NBA Dallas Mavericks basketball player Jose Juan Barea, of Puerto Rico, waves to fans during a welcoming parade in San Juan, Puerto Rico, Wednesday June 22, 2011. Dallas Mavericks won the last National Basketball Association championship. (AP Photo/Ricardo Arduengo)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/b67f32bb-dba7-4e21-ba21-ce0e52f0e35f.jpg" type="image/jpeg" medium="image" height="267" width="400" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/b67f32bb-dba7-4e21-ba21-ce0e52f0e35f.jpg" width="120" height="80" /><media:description type="plain">&lt;p&gt;NBA Dallas Mavericks basketball player Jose Juan Barea, top, of Puerto Rico, waves to fans during a welcoming parade in San Juan, Puerto Rico, Wednesday, June 22, 2011. Dallas Mavericks won the last National Basketball Association championship. (AP Photo/Ricardo Arduengo)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/c7de95e0-1cc4-456f-a147-71eb6295a4cb.jpg" type="image/jpeg" medium="image" height="267" width="400" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/c7de95e0-1cc4-456f-a147-71eb6295a4cb.jpg" width="120" height="80" /><media:description type="plain">&lt;p&gt;NBA Dallas Mavericks basketball player Jose Juan Barea, of Puerto Rico, waves a Puerto Rican flag from the top of a vehicle during a welcoming parade in San Juan, Puerto Rico, Wednesday, June 22, 2011. Dallas Mavericks won the last National Basketball Association championship. (AP Photo/Ricardo Arduengo)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content><media:content url="http://www.cdn.newsvine.com/_vine/images/ap/400/8cd3152a-9d20-4f26-af17-6c1e4abae3af.jpg" type="image/jpeg" medium="image" height="512" width="350" ><media:thumbnail url="http://www.cdn.newsvine.com/_vine/images/ap/120/8cd3152a-9d20-4f26-af17-6c1e4abae3af.jpg" width="120" height="176" /><media:description type="plain">&lt;p&gt;NBA Dallas Mavericks basketball player Jose Juan Barea, of Puerto Rico, travels on the top of a vehicle during a welcoming parade in San Juan, Puerto Rico, Wednesday, June 22, 2011. Dallas Mavericks won the last National Basketball Association championship. (AP Photo/Ricardo Arduengo)&lt;/p&gt;</media:description><media:credit role="owner" scheme="urn:yvs"></media:credit></media:content></item><item><title>Another J&amp;J recall over musty odor, for HIV drug</title>
<description><![CDATA[Johnson & Johnson is again recalling a prescription drug because of an odd musty odor likely caused by a chemical on shipping pallets.]]></description>
<dc:creator><![CDATA[Linda A. Johnson]]></dc:creator><source><![CDATA[Linda A. Johnson]]></source><link>http://www.newsvine.com/_news/2011/05/11/6624222-another-jj-recall-over-musty-odor-for-hiv-drug</link><guid>http://www.newsvine.com/_news/2011/05/11/6624222-another-jj-recall-over-musty-odor-for-hiv-drug</guid><category>business</category><category>us</category><category>drug</category><category>recall</category><category>hiv</category><category>jj</category><pubDate>Wed, 11 May 2011 14:37:46 +0000</pubDate><activity:verb>http://activitystrea.ms/schema/1.0/post</activity:verb><activity:object-type>http://activitystrea.ms/schema/1.0/generic_post</activity:object-type></item></channel></rss>